Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/49131
Type
ArticleCopyright
Open access
Collections
- IFF - Artigos de Periódicos [1300]
- INI - Artigos de Periódicos [3645]
Metadata
Show full item record
ZIKA VIRUS NS3 PROTEASE INDUCES BONE MORPHOGENETIC PROTEIN-DEPENDENT BRAIN CALCIFICATION IN HUMAN FETUSES
Author
Affilliation
Lerner Research Institute. Department of Cancer Biology and Global Center for Pathogens Research and Human Health. Cleveland Clinic. Cleveland, OH, USA.
Lerner Research Institute. Department of Cancer Biology and Global Center for Pathogens Research and Human Health. Cleveland Clinic. Cleveland, OH, USA.
University of Southern California. Keck School of Medicine. Los Angeles, CA, USA.
University of Southern California. Keck School of Medicine. Los Angeles, CA, USA.
University of Southern California. Keck School of Medicine. Los Angeles, CA, USA.
Lerner Research Institute. Department of Cancer Biology and Global Center for Pathogens Research and Human Health. Cleveland Clinic. Cleveland, OH, USA.
University of Southern California. Keck School of Medicine. Los Angeles, CA, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Icahn School of Medicine at Mount Sinai. Department of Microbiology. New York, NY, USA / Icahn School of Medicine at Mount Sinai. Division of Infectious Diseases. Department of Medicine. New York, NY, USA / Icahn School of Medicine at Mount Sinai. Global Health and Emerging Pathogens Institute. New York, NY, USA / Icahn School of Medicine at Mount Sinai. The Tisch Cancer Institute. New York, NY, USA.
University of California. David Geffen School of Medicine. Department of Microbiology and Molecular Genetics. Los Angeles, CA, USA.
University of California. David Geffen School of Medicine. Division of Pediatric Infectious Diseases. Los Angeles, CA, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em Doenças Febris Agudas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira. Departamento de Patologia. Rio de Janeiro, RJ, Brasil.
Lerner Research Institute. Department of Cancer Biology and Global Center for Pathogens Research and Human Health. Cleveland Clinic. Cleveland, OH, USA.
Lerner Research Institute. Department of Cancer Biology and Global Center for Pathogens Research and Human Health. Cleveland Clinic. Cleveland, OH, USA.
University of Southern California. Keck School of Medicine. Los Angeles, CA, USA.
University of Southern California. Keck School of Medicine. Los Angeles, CA, USA.
University of Southern California. Keck School of Medicine. Los Angeles, CA, USA.
Lerner Research Institute. Department of Cancer Biology and Global Center for Pathogens Research and Human Health. Cleveland Clinic. Cleveland, OH, USA.
University of Southern California. Keck School of Medicine. Los Angeles, CA, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Icahn School of Medicine at Mount Sinai. Department of Microbiology. New York, NY, USA / Icahn School of Medicine at Mount Sinai. Division of Infectious Diseases. Department of Medicine. New York, NY, USA / Icahn School of Medicine at Mount Sinai. Global Health and Emerging Pathogens Institute. New York, NY, USA / Icahn School of Medicine at Mount Sinai. The Tisch Cancer Institute. New York, NY, USA.
University of California. David Geffen School of Medicine. Department of Microbiology and Molecular Genetics. Los Angeles, CA, USA.
University of California. David Geffen School of Medicine. Division of Pediatric Infectious Diseases. Los Angeles, CA, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em Doenças Febris Agudas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira. Departamento de Patologia. Rio de Janeiro, RJ, Brasil.
Lerner Research Institute. Department of Cancer Biology and Global Center for Pathogens Research and Human Health. Cleveland Clinic. Cleveland, OH, USA.
Abstract
The most frequent fetal birth defect associated with prenatal Zika virus (ZIKV) infection is brain calcification, which in turn may potentially affect neurological development in infants. Understanding the mechanism could inform the development of potential therapies against prenatal ZIKV brain calcification. In perivascular cells, bone morphogenetic protein (BMP) is an osteogenic factor that undergoes maturation to activate osteogenesis and calcification. Here, we show that ZIKV infection of cultivated primary human brain pericytes triggers BMP2 maturation, leading to osteogenic gene expression and calcification. We observed extensive calcification near ZIKV+ pericytes of fetal human brain specimens and in vertically transmitted ZIKV+ human signal transducer and activator of transcription 2-knockin mouse pup brains. ZIKV infection of primary pericytes stimulated BMP2 maturation, inducing osteogenic gene expression and calcification that were completely blocked by anti-BMP2/4 neutralizing antibody. Not only did ZIKV NS3 expression alone induce BMP2 maturation, osteogenic gene expression and calcification, but purified NS3 protease also effectively cleaved pro-BMP2 in vitro to generate biologically active mature BMP2. These findings highlight ZIKV-induced calcification where the NS3 protease subverts the BMP2-mediated osteogenic signalling pathway to trigger brain calcification.
Share